Low-flow severe aortic stenosis with preserved ejection fraction, N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiovascular remodeling

Journal of Heart Valve Disease

Volumn 20, Issue 3, 2011, Pages 301-310

  Mizia Stec, Katarzyna ^a   Adamczyk, Tomasz ^a   Mizia, Magdalena ^a   Haberka, Maciej ^a   Ga̧sior, Zbigniew ^a   Trusz Gluza, Maria ^a   Tendera, Michał ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

AGED; AORTA STENOSIS; AORTA VALVE STENOSIS; ARTERY DIAMETER; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; DISEASE SEVERITY; EFFECTIVE ORIFICE AREA; FEMALE; FLOW MEDIATED DIATATION; HEART AFTERLOAD; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS INDEX; HEART LEFT VENTRICLE SYSTOLIC VOLUME; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; HUMAN; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE PRESSURE; PULSE WAVE; RELATIVE WALL THICKNESS; STROKE WORK; SYSTEMIC ARTERIAL COMPLIANCE; SYSTEMIC VASCULAR RESISTANCE; ULTRASOUND; VALVULOARTERIAL IMPEDANCE; ANALYSIS OF VARIANCE; BLOOD; CHI SQUARE DISTRIBUTION; COMPLIANCE (PHYSICAL); DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; POLAND; PULSATILE FLOW; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; VASCULAR RESISTANCE; VASODILATATION;

AGED; ANALYSIS OF VARIANCE; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; BRACHIAL ARTERY; CHI-SQUARE DISTRIBUTION; COMPLIANCE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POLAND; PULSATILE FLOW; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STROKE VOLUME; VASCULAR RESISTANCE; VASODILATION; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 79961245171     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Jander N. Low-gradient 'severe' aortic stenosis with preserved ejection fraction: New entity, or discrepant definitions? Eur Heart J Suppl 2008;10: E11-E15
2. Flachskampf FA. Severe aortic stenosis with low gradient and apparently preserved left ventricular systolic function - under-recognized or overdiagnosed? Eur Heart J 2008;29:966-968
3. Minners J, Allgeier M, Gohlke-Baerwolf Ch, Kienzle RP, Neumann FJ, Jander N. Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis. Eur Heart J 2008;29:1043-1048
4. Dumesnil JG, Pibarot P, Carabello B. Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: Implications for diagnosis and treatment. Eur Heart J 2010;31:281-289
5. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation 2007;115:2856-2864
6. Otto CM. Valvular aortic stenosis: Disease severity and timing of intervention. J Am Coll Cardiol 2006;47:2141-2151
7. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of the left ventricle hypertrophy: Patterns of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986;57:450-458
8. Feigenbaum H, Armstrong WF, Ryan T. Echocardiography. Editorial 2006. MediPage, Warsaw
9. Grossman W. Evaluation of systolic and diastolic function of the ventricles and myocardium. In: Baim DS, Grossman W (ed.) Cardiac Catheterization, Angiography, and Intervention. Lippincott, Williams and Wilkins, Philadelphia, PA, 2000:367-390
10. Garcia D, Pibarot P, Dumesnil JG, Sakr F, Durand LG. Assessment of aortic valve stenosis severity: A new index based on the energy loss concept. Circulation 2000;101:765-771
11. Palmieri V, Bella JN, Roman MJ, et al. Pulse pressure/ stroke index and left ventricular geometry and function: The LIFE Study. J Hypertens 2003;21:781-787
12. Briand M, Dumesnil JG, Kadem L, et al. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: Implications for diagnosis and treatment. J Am Coll Cardiol 2005;46:291-298
13. Mizia-Stec K, Gasior Z, Zahorska-Markiewicz B, et al. The indexes of arterial structure and function in women with simple obesity: A preliminary study. Heart Vessels 2008;23:224-229
14. Corretti MC, Anderson TJ, Benjamin EJ, et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow mediated vasodilatation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-265
15. Mizia-Stec K, Gasior Z, Mizia M, et al. Flow-mediated dilation and gender in patients with coronary artery disease: Arterial size influences gender differences in flow-mediated dilation. Echocardiography 2007;24:1051-1057
16. Asbar R, Bentos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995;26:485-490
17. .Vahanian A, Baumgartner H, Bax J, et al. Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. ESC Guidelines on the management of valvular heart disease. Eur Heart J 2007;28:230-268
18. Bonow RO, Carabello BA, Chatterjee K, et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists, ACC/AHA 2006 Guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists. J Am Coll Cardiol;48:e1-e148
19. Aurigemma GP, Silver KH, Priest MA, Gaash WH. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol 1995;26:195-202
20. Cramariuc D, Cioffi G, Rieck AE, et al. Low-flow aortic stenosis in asymptomatic patients: Valvulararterial impedance and systolic function from the SEAS Substudy. J Am Coll Cardiol Cardiovasc Imag 2009;2:390-399
21. Barasch E, Fan D, Chukwu EO, et al. Severe isolated aortic stenosis with normal left ventricular systolic function and low transvalvular gradients: Pathophysiologic and prognostic insights. J Heart Valve Dis 2008;17:81-88
22. Song BG, Park YH, Kang GH, et al. Preoperative, postoperative and one-year follow-up of N-terminal pro-B-type natriuretic peptide levels in volume overload of aortic regurgitation: Comparison with pressure overload of aortic stenosis. Cardiology 2010;116:286-291
23. Ferrari G, Sainger R, Beckmann E, et al Validation of plasma biomarkers in degenerative calcific aortic stenosis. J Surg Res 2010;163:12-17
24. Melina G, Angeloni E, Benedetto U, et al. Relationship between prosthesis-patient mismatch and pro-brain natriuretic peptides after aortic valve replacement. J Heart Valve Dis 2010;19:171-176
25. Schulz O, Rudolph A, Scheiner S, et al. Influence of acute and chronic myocardial loading conditions, function, structural changes and extracardiac factors on NT-proBNP in asymptomatic patients with preserved ejection fraction. Clin Res Cardiol 2011;100:57-65
26. Sung SH, Chuang SY, Sheu WH, et al. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population. Am J Cardiol 2009;103:1411-1416
27. Ikonomidis I, Stamatelopoulos K, Lekakis J, et al. Inflammatory and non-invasive vascular markers: The multimarker approach for risk stratification in coronary artery disease. Atherosclerosis 2008;199: 3-11
28. Poggianti E, Venneri L, Chubuchny V, et al. Aortic valve sclerosis is associated with systemic endothelial dysfunction. J Am Coll Cardiol 2003;41:136-141
29. Celik S, Durmuş I, Korkmaz L, et al. Aortic pulse wave velocity in subjects with aortic valve sclerosis. Echocardiography 2008;25:1112-1116
30. Antonini-Canterin F, Roşca M, Beladan CC, et al. Echo-tracking assessment of carotid artery stiffness in patients with aortic valve stenosis. Echocardiography 2009;26:823-831
31. .Wachtell K. Left ventricular systolic performance in asymptomatic aortic stenosis. Eur Heart J 2008;10(Suppl.E):E16-E22
32. Antonini-Canterin F, Huang G, Cervesato E, et al. Symptomatic aortic stenosis: Does systemic hypertension play an additional role? Hypertension 2003;41:1268-1272
33. Little SH, Chan KL, Burwash IG. Impact of blood pressure on the Doppler echocardiographic assessment of severity of aortic stenosis. Heart 2007;93:848-855